Skip to content
The U.S. biotechnology company will pay $116.50 for each Horizon share
Source link
Tags: acquisitions, Acquisitions/Mergers, Acquisitions/Mergers/Shareholdings, Amgen, Amgen Inc, AMGN, banking, Banking/Credit, Biopharmaceuticals, Biotechnology, C&E Industry News Filter, Commercial Banking, Content Types, corporate, Corporate Actions, Corporate/Industrial News, credit, Factiva Filters, Financial Services, healthcare, Healthcare/Life Sciences, Horizon Therapeutics, HZNP, industrial news, life sciences, Merck, mergers, MRK, Ownership Changes, PFE, Pfizer, Pharmaceuticals, Retail, Retail/Wholesale, Robert Bradway, shareholdings, SYND, wholesale, Wholesalers, WSJ-PRO-WSJ.com, wsjfinance-ws
